Baughman RP, Lower EE, du Bois RM: Sarcoidosis. Lancet. 2003, 361: 1111-1118. 10.1016/S0140-6736(03)12888-7.
Article
PubMed
CAS
Google Scholar
Baughman RP, Nagai S, Balter M, Costabel U, Drent M, du BR, et al: Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis. 2011, 28: 56-64.
PubMed
CAS
Google Scholar
Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du BR, et al: ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999, 16: 149-173.
PubMed
CAS
Google Scholar
Lazarus A: Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Mon. 2009, 55: 649-660. 10.1016/j.disamonth.2009.04.008.
Article
PubMed
Google Scholar
Thomas KW, Hunninghake GW: Sarcoidosis. JAMA. 2003, 289: 3300-3303. 10.1001/jama.289.24.3300.
Article
PubMed
Google Scholar
Iannuzzi MC, Rybicki BA, Teirstein AS: Sarcoidosis. N Engl J Med. 2007, 357: 2153-2165. 10.1056/NEJMra071714.
Article
PubMed
CAS
Google Scholar
Cui A, Anhenn O, Theegarten D, Ohshimo S, Bonella F, Sixt SU, et al: Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease. Respiration. 2010, 80: 372-378. 10.1159/000245332.
Article
PubMed
CAS
Google Scholar
Antoniou KM, Tzouvelekis A, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Rachiotis G, et al: Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest. 2006, 130: 982-988. 10.1378/chest.130.4.982.
Article
PubMed
Google Scholar
Tzouvelekis A, Anevlavis S, Bouros D: Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?. Respir Res. 2006, 7: 82-10.1186/1465-9921-7-82.
Article
PubMed
PubMed Central
Google Scholar
Agostini C, Facco M, Siviero M, Carollo D, Galvan S, Cattelan AM, et al: CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med. 2000, 162: 1466-1473.
Article
PubMed
CAS
Google Scholar
Tolnay E, Kuhnen C, Voss B, Wiethege T, Muller KM: Expression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis. Virchows Arch. 1998, 432: 61-65. 10.1007/s004280050135.
Article
PubMed
CAS
Google Scholar
Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T: Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med. 2002, 166: 382-385. 10.1164/rccm.2103112.
Article
PubMed
Google Scholar
Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F: Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest. 2003, 123: 1520-1526. 10.1378/chest.123.5.1520.
Article
PubMed
CAS
Google Scholar
Semenza GL: HIF-1 and human disease: one highly involved factor. Genes Dev. 2000, 14: 1983-1991.
PubMed
CAS
Google Scholar
Schmid T, Zhou J, Brune B: HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med. 2004, 8: 423-431. 10.1111/j.1582-4934.2004.tb00467.x.
Article
PubMed
CAS
Google Scholar
Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003, 3: 721-732. 10.1038/nrc1187.
Article
PubMed
CAS
Google Scholar
Strieter RM: Masters of angiogenesis. Nat Med. 2005, 11: 925-927. 10.1038/nm0905-925.
Article
PubMed
CAS
Google Scholar
Albina JE, Mastrofrancesco B, Vessella JA, Louis CA, Henry WL, Reichner JS: HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol. 2001, 281: C1971-C1977.
PubMed
CAS
Google Scholar
Tzouvelekis A, Harokopos V, Paparountas T, Oikonomou N, Chatziioannou A, Vilaras G, et al: Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. Am J Respir Crit Care Med. 2007, 176: 1108-1119. 10.1164/rccm.200705-683OC.
Article
PubMed
Google Scholar
Tzouvelekis A, Aidinis V, Harokopos V, Karameris A, Zacharis G, Mikroulis D, et al: Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis. Respir Res. 2009, 10: 14-10.1186/1465-9921-10-14.
Article
PubMed
PubMed Central
Google Scholar
Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, et al: The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature. 2004, 428: 328-332. 10.1038/nature02329.
Article
PubMed
CAS
Google Scholar
Li J, Martinka M, Li G: Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis. 2008, 29: 1373-1379. 10.1093/carcin/bgn086.
Article
PubMed
Google Scholar
Ozer A, Bruick RK: Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4. Cell Cycle. 2005, 4: 1153-1156. 10.4161/cc.4.9.2040.
Article
PubMed
CAS
Google Scholar
Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP: CXC chemokines in angiogenesis. Cytokine Growth Factor Rev. 2005, 16: 593-609. 10.1016/j.cytogfr.2005.04.007.
Article
PubMed
CAS
Google Scholar
Strieter RM, Belperio JA, Burdick MD, Keane MP: CXC chemokines in angiogenesis relevant to chronic fibroproliferation. Curr Drug Targets Inflamm Allergy. 2005, 4: 23-26. 10.2174/1568010053622902.
Article
PubMed
CAS
Google Scholar
Wenger RH: Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 2002, 16: 1151-1162. 10.1096/fj.01-0944rev.
Article
PubMed
CAS
Google Scholar
Ozer A, Wu LC, Bruick RK: The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci U S A . 2005, 102: 7481-7486. 10.1073/pnas.0502716102.
Article
PubMed
CAS
PubMed Central
Google Scholar
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998, 4: 844-847. 10.1038/nm0798-844.
Article
PubMed
CAS
Google Scholar
Kambouchner M, Pirici D, Uhl JF, Mogoanta L, Valeyre D, Bernaudin JF: Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas. Eur Respir J. 2011, 37: 835-840. 10.1183/09031936.00086410.
Article
PubMed
CAS
Google Scholar
Murdoch C, Giannoudis A, Lewis CE: Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood. 2004, 104: 2224-2234. 10.1182/blood-2004-03-1109.
Article
PubMed
CAS
Google Scholar